In our formula we are using 20% Azeclair, a solution containing 6% pure Potassium Azeloyl Diglycinate (PAD). While 6% might not sound like a high number, when it comes to PAD, it is an outstanding amount. The molecule is effective already and typically used at 1-3%. Studies done by the ingredient’s manufacturer show that 3% PAD (or 10% Azeclair) is an effective amount in normalizing oil production and evening the skin tone, while a study published in the Journal of Dermatological Treatment used 5% PAD for the management of rosacea.
Geek tip: Based on our experience, those who are sensitive to niacinamide tend to find aPAD an especially helpful addition to their skincare routine.
Cruelty-free | Vegan | Fragrance & Essential oil free | Gluten-free | Malassezia-safe | Pregnancy-safe
Who is it for?
how to use it?
Apply a few drops to the face after cleansing, before using emulsions and/or creams. Can be used either in the AM and/or PM.
Shelf life: 2 years from production (unopened), 6 months PAO (period after opening)
Ingredients & Research
Potassium Azeloyl Diglycinate - A new generation azelaic acid derivative designed to be water-soluble and thus enable light formulas. It has a similar effect to the 3-in-1 clinical active azelaic acid that helps to normalize oil production, evening the skin tone, reducing blemishes, pigmentation and redness. There are a few studies using PAD already: two used it for the management of rosacea here and here, and another one used it for the management of melasma.
Allantoin - A classic skincare ingredient known for its skin soothing and skin protecting abilities.
Glycerin & Methyl-Gluceth 20 - A gentle humectant combination to help the skin to hold onto water.
full inci list:
Water, Potassium Azeloyl Diglycinate, Propanediol, Glycerin, Methyl-Gluceth 20, Allantoin, Hydroxyethylcellulose, Xanthan Gum, Citric Acid, Ethylhexylglycerin, Phenoxyethanol
Berardesca, Enzo, et al. "Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea." Journal of cosmetic dermatology 11.1 (2012): 37-41.
Viyoch, Jarupa, et al. "Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study." Current Therapeutic Research 71.6 (2010): 345-359.
Veraldi, Stefano, et al. "Treatment of symptoms of erythemato-telangiectatic rosacea with topical potassium azeloyl diglycinate and hydroxypropyl chitosan: Results of a sponsor-free, multicenter, open study." Journal of Dermatological Treatment 26.2 (2015): 191-192.